Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-3-29
pubmed:abstractText
A new intramuscular DNA electrotransfer method for erythropoietin (EPO) expression was evaluated in the natural mouse model of human beta-thalassemia (Hbb-thal1) in terms of its ability to reverse the anemia and improve the thalassemic features of erythrocytes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0301-472X
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
295-300
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11274756-Animals, pubmed-meshheading:11274756-Cytomegalovirus, pubmed-meshheading:11274756-DNA, Recombinant, pubmed-meshheading:11274756-Disease Models, Animal, pubmed-meshheading:11274756-Electroporation, pubmed-meshheading:11274756-Erythropoietin, pubmed-meshheading:11274756-Female, pubmed-meshheading:11274756-Gene Deletion, pubmed-meshheading:11274756-Gene Therapy, pubmed-meshheading:11274756-Genetic Vectors, pubmed-meshheading:11274756-Globins, pubmed-meshheading:11274756-Hematocrit, pubmed-meshheading:11274756-Injections, Intramuscular, pubmed-meshheading:11274756-Mice, pubmed-meshheading:11274756-Mice, Inbred C57BL, pubmed-meshheading:11274756-Mice, Mutant Strains, pubmed-meshheading:11274756-Promoter Regions, Genetic, pubmed-meshheading:11274756-Recombinant Fusion Proteins, pubmed-meshheading:11274756-Transgenes, pubmed-meshheading:11274756-beta-Thalassemia
pubmed:year
2001
pubmed:articleTitle
Improvement of mouse beta-thalassemia by electrotransfer of erythropoietin cDNA.
pubmed:affiliation
Laboratoire Expérimental de Thérapie Génique, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France. letg@chu-stlouis.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't